Narcan (naloxone HCl)
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Recalls of antihistamines, decongestants and nasal sprays.
314 recalls in this category, newest first.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Microbial Contamination of Non-Sterile Products: Product confirmed to have yeast
Superpotent Drug
Superpotent Drug
Superpotent Drug
Labeling: Incorrect or Missing Lot and/or Expiration date.
Failed Impurities/Degradation Specifications
Failed Stability Specifications.
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.
CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.
Microbial contamination of non-sterile product
Microbial Contamination of Non-sterile Products: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
Lack of Assurance of Sterility
cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.